127 related articles for article (PubMed ID: 2801316)
1. Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice.
Björk J; Kleinau S
Agents Actions; 1989 Jun; 27(3-4):319-21. PubMed ID: 2801316
[TBL] [Abstract][Full Text] [Related]
2. Linomide, a new immunomodulatory drug, shows different effects on homologous versus heterologous collagen-induced arthritis in rats.
Kleinau S; Larsson P; Björk J; Holmdahl R; Klareskog L
Clin Exp Immunol; 1989 Oct; 78(1):138-42. PubMed ID: 2805418
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions.
Shirkey BL; Slavin S; Vistica BP; Podgor MJ; Gery I
Clin Exp Immunol; 1997 Jun; 108(3):539-44. PubMed ID: 9182904
[TBL] [Abstract][Full Text] [Related]
4. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions.
Bai XF; Shi FD; Zhu J; Xiao BG; Hedlund G; Link H
J Neuroimmunol; 1997 Jun; 76(1-2):177-84. PubMed ID: 9184648
[TBL] [Abstract][Full Text] [Related]
5. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses.
Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H
Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
Lehmann D; Karussis DM; Fluresco D; Mizrachi-Koll R; Ovadia H; Shezen E; Kalland T; Abramsky O
J Neuroimmunol; 1997 Apr; 74(1-2):102-10. PubMed ID: 9119961
[TBL] [Abstract][Full Text] [Related]
7. Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system.
Hedlund G; Link H; Zhu J; Xiao BG
Int Immunopharmacol; 2001 Jun; 1(6):1123-30. PubMed ID: 11407306
[TBL] [Abstract][Full Text] [Related]
8. Linomide increases plasma corticosterone in normal rats, but does not prevent the inhibitory action of IL-1 on beta-cells in vivo or ex vivo.
Christensen UB; Mauricio D; Reimers JI; Andersen HU; Kalland T; Nerup J; Mandrup-Poulsen T
Autoimmunity; 1996; 23(4):257-68. PubMed ID: 8915032
[TBL] [Abstract][Full Text] [Related]
9. Linomide enhances apoptosis in CD4+CD8+ thymocytes.
Harring AC; Xu Z; Andersson G; Hedlund G
Scand J Immunol; 1997 Nov; 46(5):488-94. PubMed ID: 9393631
[TBL] [Abstract][Full Text] [Related]
10. The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
Morecki S; Nabet C; Falk P; Fridkis-Hareli M; Pecht I; Mond JJ; Slavin S
Autoimmunity; 1997; 25(4):223-32. PubMed ID: 9344330
[TBL] [Abstract][Full Text] [Related]
11. The immune modulator Linomide prevents neuronal death in injured peripheral nerves of the mouse.
Ekström PA; Hedlund G; Karlsson J; Andersson G
Neuroreport; 1998 May; 9(7):1337-41. PubMed ID: 9631425
[TBL] [Abstract][Full Text] [Related]
12. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Abdul-Hai A; Hershkoviz R; Weiss L; Lider O; Slavin S
Int Immunopharmacol; 2005 Feb; 5(2):231-9. PubMed ID: 15652754
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
Peltoniemi J; Broberg EK; Nygårdas M; Erälinna JP; Waris M; Hukkanen V
Int Immunopharmacol; 2006 May; 6(5):817-29. PubMed ID: 16546713
[TBL] [Abstract][Full Text] [Related]
14. Linomide, an immunomodulator that inhibits Th1 cytokine gene expression.
Arad G; Katzenellenbogen M; Levy R; Slavin S; Kaempfer R
Int Immunol; 1996 Oct; 8(10):1603-7. PubMed ID: 8921440
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of wound healing by the immunomodulator LS-2616 (Linomide).
Lepistö J; Laato M; Niinikoski J; Lundberg C; Gerdin B
World J Surg; 1994; 18(6):818-20; discussion 821. PubMed ID: 7846902
[TBL] [Abstract][Full Text] [Related]
16. Linomide activates the adrenocortical axis in the rat: inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone.
Weidenfeld J; Karussis D; Abramsky O; Lehmann D; Arbell I; Ovadia H
J Neuroimmunol; 1997 Oct; 79(1):49-53. PubMed ID: 9357446
[TBL] [Abstract][Full Text] [Related]
17. Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice.
del Real G; Llorente M; Boscá L; Hortelano S; Serrano A; Lucas P; Gómez L; Torán JL; Redondo C; Martínez C
AIDS; 1998 May; 12(8):865-72. PubMed ID: 9631139
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
19. Linomide administration following bone marrow transplantation in mice.
Weiss L; Abdul-Hai A; Shufaro Y; Reich S; Slavin S
Cancer Immunol Immunother; 2002 Dec; 51(11-12):596-602. PubMed ID: 12439604
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic effects of the quinoline-3-carboxamide linomide.
Vukanovic J; Passaniti A; Hirata T; Traystman RJ; Hartley-Asp B; Isaacs JT
Cancer Res; 1993 Apr; 53(8):1833-7. PubMed ID: 7682157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
